Yokukansan, a Traditional Japanese Medicine, Enhances the Glutamate Transporter GLT‐1 Function in Cultured Rat Cortical Astrocytes

Authors:

Abstract
Astrocytes carry two glutamate transporters—GLAST and GLT‐1—the latter of which is responsible for >90% of glutamate uptake activity in the brain; however, under culture conditions, the GLT‐1 expression in astrocytes is exceedingly low, as is the glutamate uptake activity mediated by GLT‐1. This study aimed to elucidate the effects of yokukansan (YKS) in relation to the GLT‐1‐mediated regulation of extracellular glutamate concentrations. Thus, we treated cultured astrocytes with tumor necrosis factor‐α (TNF‐α) and dibutyryl‐cAMP (dBcAMP) (hereinafter, referred to as “TA”) to increase GLT‐1 expression and then functionally examined how YKS would affect glutamate uptake ability derived from GLT‐1. Contrary to expectations, although the TA treatments did not affect the uptake activity, YKS significantly augmented it. Conversely, GLAST‐derived glutamate uptake was significantly reduced by TA treatments but was unaffected by YKS. Subsequently, we analyzed the GLT‐1 protein and mRNA levels and found that TA treatments had significantly increased them, which were then further augmented by YKS. These findings suggest that YKS enhances GLT‐1‐derived glutamate transport functions in TA‐treated cultured astrocytes and that this process entails increased GLT‐1 protein and mRNA levels. This type of mechanism may contribute to the YKS‐mediated regulation of extracellular glutamate concentrations.

This publication has 43 references indexed in Scilit: